ArticleTranslational andrology and urology2025
Association between cardiometabolic index and overactive bladder in U.S. adults: findings from NHANES [2017-2020].
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The cardiometabolic index (CMI) is a novel marker of visceral obesity and dyslipidemia. This study aimed to comprehensively evaluate the potential association between CMI and the odds of overactive bladder (OAB). Methods: In this cross-sectional study, a total of 1,740 participants from the National Health and Nutrition Examination Survey (NHANES) conducted between 2017 and 2020 were enrolled. We employed a multivariate logistic regression model and conducted subgroup analyses to investigate the association between CMI and the prevalence of OAB. Curve fitting and threshold effect analysis were performed to assess the nonlinear relationship between CMI and OAB. The predictive efficacy of CMI, lipid accumulation product (LAP), visceral adiposity index (VAI), body mass index (BMI), weight-adjusted waist index (WWI), and triglyceride glucose index (TyG) on the incidence of OAB was determined by drawing receiver operating characteristic (ROC) curves. Results: After adjusting for potential confounding factors, logistic regression analysis showed that higher CMI levels were significantly associated with a higher prevalence of OAB. After full adjustment for the model, a positive association was observed [odds ratio (OR) =1.25; 95% confidence interval (CI): 1.06-1.47], indicating that the odds of OAB increased by 25% for each unit increase in CMI. Subgroup analyses demonstrated that this association remained consistent across most subgroups. Smoothing curve fitting further confirmed a positively correlated nonlinear relationship between CMI and OAB odds. By plotting the ROC curves, we found that the area under the curve (AUC) for CMI, LAP, VAI, BMI, TyG, and WWI were 0.719, 0.715, 0.713, 0.712, 0.712, and 0.712, respectively. Conclusions: This study suggests that CMI is positively associated with the incidence of OAB in U.S. adults. Therefore, CMI may be a predictor of OAB occurrence.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.